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ABSTRACT 
Aim: Studies in rodents have shown that leptin controls sugars and glutamine entry in 
the enterocytes by regulating membrane transporters. Here, we have examined the effect 
of leptin on sugar and amino acids absorption in the human model of intestinal cells 
Caco-2 and investigated the transporters involved. 
Methods: Substrate uptake experiments were performed in Caco-2 cells, grown on 
plates, in the presence and the absence of leptin and the expression of the different 
transporters in brush border membrane vesicles was analysed by Western blot. 
Results: Leptin inhibited 0.1 mM α-methyl-D-glucoside uptake after 5 or 30 min 
treatment, and decreased SGLT1 protein abundance in the apical membrane. Uptake of 
20 µM glutamine and 0.1 mM phenylalanine was also inhibited by leptin, indicating 
sensitivity to the hormone of the Na+-dependent neutral amino acid transporters ASCT2 
and B0AT1. This inhibition was accompanied by a reduction of the transporters 
expression at the brush-border membrane. Leptin also inhibited 1 mM proline and β-
alanine uptake in Na+ medium at pH 6, conditions for optimal activity of the H+-
dependent neutral amino acid transporter PAT1. In this case, abundance of PAT1 in the 
brush-border membrane after leptin treatment was not modified. Interestingly, leptin 
inhibitory effect on β-alanine uptake was reversed by the PKA inhibitor H-89 
suggesting involvement of PKA pathway in leptin´s regulation of PAT1 activity.  
Conclusion: These data show in human intestinal cells that leptin can rapidly control 
the activity of physiologically relevant transporters for rich-energy molecules, i.e D-
glucose (SGLT1) and amino acids (ASCT2, B0AT1 and PAT1). 
 
 Keywords: amino acid transporters, Caco-2 cells, leptin, sodium-dependent glucose 
transporter 1, western blot 
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INTRODUCTION 
Leptin was discovered in 1994 and described as an adipostatic signal controlling body 
weight and adiposity (Zhang et al. 1994). Nowadays, however, leptin is considered as a 
multifunctional hormone with many peripheral actions including immune function, 
bone development, growth and fertility (Gertler 2009). Accordingly, leptin production 
has been found in many different tissues in addition to adipose cells (Bado et al. 1998, 
Cammisotto et al. 2010, De Matteis et al. 2002, Martinez-Ansó et al. 1999) and leptin 
receptors are expressed ubiquitously in peripheral tissues (Gertler 2009, Margetic et al. 
2002). 
In the stomach, after a meal, leptin is secreted into the gastric lumen by pepsinogen-
containing secretory granules of the chief cells (Bado et al. 1998, Cammisotto et al. 
2005) together with the leptin soluble receptor which co-localizes in those secretory 
granules (Cammisotto et al. 2006). Leptin secretion from the gastric mucosa is also 
regulated by acetylcholine released by the vagus nerve, several hormones like secretin, 
CCK and insuline and the nutritional status of the body (Bado et al.1998; Cammisotto et 
al. 2010). Despite the low pH of the gastric juice, leptin remains stable and is able to 
reach the intestinal lumen because the binding to its soluble receptor protects it from 
degradation (Guilmeau et al. 2004).  
In agreement with these data, we have demonstrated that leptin receptors are expressed 
in both the apical and basolateral membrane of the intestinal absorptive cells 
(Barrenetxe et al. 2002) indicating that the hormone can access the enterocytes from the 
blood and from the intestinal lumen. We have also shown in rodents using in vitro and 
in vivo techniques, that leptin inhibits the sugar active transporter SGLT1, acting from 
the luminal side (Barrenetxe et al. 2001, Ducroc et al. 2005, Iñigo et al. 2004, Iñigo et 
al. 2007, Lostao et al. 1998). This effect is mediated by PKA and PKC (Barrenetxe et 
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al. 2004, Ducroc et al. 2005) and is reversible (Iñigo et al. 2007). Interestingly, luminal 
leptin increases peptide absorption in rat intestine in vivo and in Caco-2 cells acting 
from the apical membrane (Buyse et al. 2001), as well as butyrate uptake in the same 
cell line (Buyse et al. 2002). In addition, it has been recently demonstrated that luminal 
leptin also increases GLUT2 and GLUT5 insertion in the apical membrane of the rat 
enterocytes leading to an enhanced galactose and fructose absorption (Sakar et al. 
2009). Finally, we recently showed in rat small intestine that leptin inhibits glutamine 
transport by regulating activity and gene expression of its transporters ASCT2 and 
B0AT1 (Ducroc et al. 2010). 
Altogether, these observations support the view that gastric leptin can exert a regulatory 
role on intestinal nutrients absorption in the postprandial state. However, whether leptin 
can modulate sugars or amino acids absorption in human intestine is not documented. 
The purpose of the present study was therefore to extent our previous work and 
investigate in Caco-2 cells, a model of human intestinal epithelial cells, the effect of 
apical leptin on the absorption of sugars (α-methyl-glucoside; MG) and the amino acids 
glutamine (Gln), phenylalanine (Phe), β-alanine (β-Ala) and Proline (Pro), and the 
transporters involved.  
The results show that leptin regulates the uptake of MG and Gln by down-regulating the 
traffic of the corresponding transporters SGLT1 (SLC5A1), ASCT2 (SLC1A5) and 
B0AT1 (SLC6A19) to the plasma membrane. Transport of Pro and β-Ala was also 
found reduced by leptin, as the result of a decreased activity of the proton-coupled 
amino acid transporter PAT1 (SLC36A1) via leptin activation of an H-89 sensitive 
pathway.  
MATERIAL AND METHODS 
Materials  
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The Caco-2 cell line PD7 clone was kindly provided by Dr. Edith Brot-Laroche. The 
radiolabeled products [14C]-α-methyl-glucoside (303 mCi ml-1), L-[2, 3-3H]-proline (40 
Ci ml-1), L-[3, 4-3H]-glutamine (30 Ci ml-1) and L-[3,4-3H]-phenylalanine (30 Ci ml-1) 
were purchased from Perkin Elmer Inc. (Life Sciences, Boston, MA, USA) and β-[3-
3H]-alanine (50 Ci ml-1) from American Radiolabeled Chemicals Inc (St Louis, MO, 
USA). All unlabeled amino acids and α-methyl-glucoside, were obtained from Sigma 
Chemicals Inc (St Louis, MO, USA) and human leptin from Peprotech Inc (UK). 
Cell culture 
Caco-2 cells were maintained in a humidified atmosphere of 5% CO2-95% at 37ºC. 
Cells (passages 50-70) were grown in Dulbecco´s Modified Eagles medium (DMEM) 
(Gibco Invitrogen, Paisley, UK) supplemented with 10% fetal bovine serum (FBS), 1% 
non essential amino acids, 1% penicillin (1000 U ml-1), 1% streptomycin (1000 µg ml-1) 
and 1% amphoterycin (250 U ml-1). Once the cells reached 80% confluence, they were 
dissociated with 0.05% trypsin-EDTA and sub-cultured on 25 or 75 cm2 plastic flasks at 
a density of 25 x 104 cells cm-2. For transport studies, the cells were seeded at a 6 x 104 
cells cm-2 density in 24 well culture plates. Culture medium was replaced every 2 days. 
Cell confluence was confirmed by microscopic observance. Experiments were 
performed 17-21 days post-seeding.  
Uptake measurements 
For sugar assays, cells were pre-incubated in serum and glucose-free DMEM, 2 h before 
the beginning of the experiment. In this medium, used as uptake buffer, 0.1 mM MG 
(SGLT1 specific substrate) was diluted with traces of 14C MG (0.3 µCi ml-1). For amino 
acid uptake assays, all the different amino acids (0.1 mM and 20 µM Gln, 0.1 mM Phe, 
1 mM β-Ala and Pro) with traces of their respective radiolabeled substrates (2 µCi ml-1) 
were diluted in Krebs modified buffer (also referred as Na+ medium): 5.4 mM KCl, 2.8 
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mM CaCl2, 1 mM MgSO4, 0.3  mM NaH2PO4, 137 mM NaCl, 0.3 mM KH2PO4, 10 
mM glucose and 10 mM HEPES/Tris (pH 7.5) or Mes/Tris (pH 6). To check if the 
presence of glutamine in the incubation medium could modify the uptake of the amino 
acid, cells were incubated for 2 h in the absence of glutamine. The results obtained were 
similar to those in which the cells had been incubated with glutamine until the 
beginning of the experiment. Therefore, glutamine was present routinely in the 
incubation medium. In the experiments performed in Na+-free medium, NaCl was 
replaced with choline chloride.  
A similar protocol for MG and amino acids uptake assays was followed. Cells were 
gently washed with substrate free medium and uptake was initiated by adding 0.5 ml 
uptake buffer in the absence or presence of 0.2 or 8 nM human leptin. These leptin 
concentrations were chosen because they correspond to the leptin plasma levels in 
normal and obese individuals respectively and were used in our previous works 
(Heinonen et al. 2005, Lostao et al. 1998). In the experiments in which the PKA 
inhibitor H-89 (Calbiochem, Nottingham, UK) was used, a set of cells were pre-
incubated for 30 min with the corresponding uptake buffer containing 1 µM H-89, 
before the addition of the substrate uptake solution with or without leptin that also 
contained H-89. In these studies, another set of cells where preincubated for the same 
time with the corresponding uptake buffer without H-89 before measuring the substrate 
uptake. After an incubation period of 5 or 30 min at 37ºC, uptake was stopped with ice 
cold free-substrate buffer followed by aspiration. Cells were again washed twice with 
ice-cold buffer to eliminate non-specific radioactivity fixation and were finally 
solubilized in 500 µl 1% Triton X-100 in 0.1 N NaOH. Samples (100 µl) were taken to 
measure radioactivity by liquid scintillation counting. Protein concentration was 
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determined by Bradford method (Bio-Rad Protein Assay, Bio-Rad laboratories, 
Hercules, CA). 
All the uptake experiments were performed in cell monolayers grown on culture plates. 
Repetition of some of these studies on cell monolayers grown on permeable membrane 
filters showed the same effect of leptin indicating that the support did not affect the 
expression of the nutrient´s transporters or leptin receptor.  
Western blot analysis 
Cells grown on 75 cm2 plastic flasks were incubated for 30 min in the presence of 0.1 
mM MG, Gln or 1 mM β-Ala with or without 8 nM leptin. After the incubation period, 
brush-border membrane vesicles (BBMV) were isolated from each flask by MgCl2 
precipitation method (Garriga et al. 1999, Shirazy-Beechey et al. 1990). The protein 
content of the vesicles was determined by the Bradford method (Bio-Rad Protein Assay, 
Bio-Rad laboratories, Hercules, CA). Alkaline phosphatase enrichment of the vesicles 
was determined by Cobas Mira S auto analyser (Roche Diagnostics, Frenchs Forests, 
NSW, Australia) and was 2.5-3 fold higher than the cells homogenate.  
Solubilized proteins (20 µg) were then resolved by electrophoresis on 12% SDS-PAGE 
mini gels. The resolved proteins were transferred to a PVDF membrane (Hybond P, GE 
Healthcare) and after blocking in TBS buffer with 3% of BSA for three hours at room 
temperature (RT), subjected to immunoblot analysis with different primary antibodies 
overnight at 4ºC. The antibodies, used at 1:1,000, were the following: anti-SGLT1 
antibody (generous gift from Ernest M. Wright) (Lostao et al. 1995); anti-B0AT1 
(generous gift from François Verrey) (Romeo et al. 2006); anti-ASCT2 antibody (Santa 
Cruz Biotech.). A polyclonal anti-PAT1 antibody raised against residues 107-119 of 
human PAT1 (Abyntek, Spain) was used at 1:200 dilution. After the incubation with the 
different antibodies, the membranes were washed three times in TBS-Tween 0.15% and 
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incubated one hour at RT with the corresponding peroxidase conjugated secondary 
antibody (Santa Cruz Biotech.). The immunoreactive bands corresponding to PAT-1 
disappeared after pre-incubation of the primary antibody with its corresponding control 
peptide, indicating its specificity. 
Membranes were stripped and immunoblotted again with a monoclonal β-actin antibody 
(Santa Cruz Biotech.) used at 1:1,000, in order to perform the loading control of the 
different wells. The immunoreactive bands were detected by enhanced 
chemiluminiscence (Super Signal West Dura, Thermo Scientific) and quantified by 
densitometric analysis (Gel Pro Analyser 3.2). The results are expressed as the ratio 
protein content/β-actin in % in relation to the corresponding control value which was 
arbitrarily set to 100.  
Statistical analysis 
Results of transport experiments are expressed as nmol mg-1 of protein. All data are 
presented as % compared to controls which are normalized at 100%. Statistical 
differences were evaluated by the two-way ANOVA test or the one-way ANOVA test 
followed by the Dunnett post-hoc test or Student t-test for parametric analysis and U 
Mann-Whitney test for non-parametric one. Differences were considered as statistically 
significant at p<0.05. The calculations were performed using the SPSS/WINDOWS 
VERSION 15.0 statistical package (SPSS. Chicago, IL, USA) 
RESULTS 
Leptin inhibits a-methyl-glucoside (MG) uptake  
The effect of 0.2 nM and 8 nM leptin on 0.1 mM MG uptake was measured after 5 and 
30 min incubation. MG uptake after 5 min in the absence of leptin (control value) 
ranged from 0.20 to 0.47 nmol mg-1 of protein, whereas after 30 min it ranged from 0.93 
to 1.37 nmol mg-1 of protein. As shown in Fig.1a, leptin inhibited by ~25-30% the sugar 
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uptake at both concentrations. This effect was statistically significant at 5 min, while at 
30 min only the highest concentration of leptin was able to significantly reduce the 
sugar uptake. Under this condition (30 min incubation with 8 nM leptin) this effect was 
accompanied by a decrease on the amount of SGLT1 (75 kDa) (Lostao et al. 1995) in 
the BBMV of Caco-2 cells.  
We previously demonstrated that PKA is involved in the inhibitory effect of leptin on 
intestinal sugar transport in rat (Barrenetxe et al. 2004). We therefore investigated 
whether a PKA-dependent pathway could also be implicated in leptin inhibition of 
sugar transport in Caco-2 cells. The uptake of 0.1 mM MG was measured in the 
presence of 8 nM leptin with and without pre-incubation of the cells for 30 min with the 
PKA inhibitor H-89. The results showed that H-89 did not modify MG uptake neither in 
the absence nor in the presence of leptin, indicating that the action of the hormone is not 
mediated by PKA. 
Leptin inhibits amino acids uptake 
The effect of leptin on glutamine uptake was also analysed under the same conditions as 
MG. After 5 min incubation, 0.2 and 8 nM leptin reduced 0.1 mM Gln uptake by ~30% 
and ~50% respectively. At 30 min, the inhibition was similar (~30%) for both hormone 
concentrations (Fig 2A). In these experiments, Gln uptake values in the absence of 
leptin at 5 min ranged from 1.04 to 1.50 nmol mg-1 protein, and at 30 min from 2.17 to 
4.09 nmol mg-1 of protein.  
The intestinal transport of Gln from the apical membrane of the enterocytes is mainly 
mediated by two Na+-dependent transporters: B0AT1 (SLC6A19), with a K0.5 of 0.6-4 
mM, and ASCT2 (SLC1A5) with a K0.5 of ~20 µM [7, 8, 38, 41] and only weakly by 
the apical Na+-independent heterodimeric transporter rBAT/b0,+AT 
(SLC31A1/SLC7A9) with a Ki of ~400 µM (Broer 2008, Rajan et al. 2000). To 
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investigate which of the Gln transporters could be implicated in the reduction of the 
amino acid uptake by leptin, we studied the uptake of Gln at the concentration of 20 µM 
after 30 min (control values ranged from 0.49 to 0.54 nmol mg-1 of protein) in the 
presence of 8 nM leptin or 25 mM Phe, since Phe can not be transported by ASCT2 but 
is a specific substrate of B0AT1 (Broer 2008). As shown in Fig. 2b, Phe did not inhibit 
Gln uptake indicating that B0AT1 was not contributing to the amino acid transport. 
Nevertheless, leptin reduced by 20% the Phe-insensitive uptake of Gln, indicating that 
ASCT2 is inhibited by the hormone. Uptake of 0.1 mM Phe (B0AT1-mediated 
transport) was also measured in the presence of 0.2 and 8 nM leptin at 5 and 30 min 
(Fig. 2c). Phe uptake in control conditions was lower than that observed with 0.1 mM 
Gln: values ranged from 0.46 to 0.74 nmol mg-1 of protein at 5 min and from 1.94 to 
3.01 nmol mg-1 of protein at 30 min. Phe uptake was also inhibited by leptin, although 
with less potency than Gln uptake (Fig. 2c), demonstrating the sensitivity of B0AT1 to 
the hormone. In order to investigate the relative contribution of  the Na+-independent 
transporter rBAT/b0,+AT on Gln uptake and its possible regulation by leptin, we studied 
the uptake of  0.1 mM Gln after 30 min, in the presence and in  the absence of 8 nM 
leptin in Na+ and Na+-free medium. In the absence of Na+, Gln uptake was reduced by 
80% and was not affected by leptin, indicating minimal participation of rBAT/b0,+AT in 
Gln uptake in Caco-2 cells  and unsensitivity to the hormone (Fig. 2d). 
The expression of B0AT1 and ASCT2 in Caco-2 BBMV in the presence and the 
absence of leptin was then analysed by Western blot (Fig 3). As occurred with SGLT1, 
leptin decreased the expression of both B0AT1 (~60 kDa) (Romeo et al. 2006) and 
ASCT2 (~60 kDa) (Nose et al. 2010) in BBMV compared with their expression in 
control condition, in line with the reduced uptake of Gln observed in the transport 
experiments. As for the sugar uptake experiments, we analysed the possible implication 
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of PKA in the leptin regulation of Gln uptake. Figure 3b shows that pre-incubation of 
the cells with H-89 did not affect basal uptake of 0.1 mM Gln. However, H-89 
enhanced the inhibitory effect of leptin on Gln uptake suggesting the involvement of a 
PKA-dependent pathway in leptin action. 
PAT1 (SLC36A1) is responsible for the H+-coupled amino acid transport through the 
apical membrane of Caco-2 cells (Chen et al. 2003). In order to investigate whether this 
transporter could be also regulated by leptin, we first checked its functional presence in 
the Caco-2 PD7 clone. Uptake of 1 mM proline (30 min) in the presence of Na+ 
increased by ~20 % compared with the uptake in the absence of Na+ (Fig. 4a). When the 
medium pH decreased from 7.5 to 6, Pro uptake increased by 1.6 and 1.7 fold in the 
absence and in the presence of Na+ respectively, being the highest in the presence of Na+ 
at pH 6 (Fig. 4a) and indicating PAT1 activity in this Caco-2 clone. We thus 
investigated the effect of 0.2 and 8 nM leptin on the uptake of 1mM Pro and β-Ala (a 
PAT1 but not B0AT1 substrate) (Broer 2008), at pH 6 in the presence of Na+ after 5 and 
30 min incubation. As shown in Fig. 4b, leptin inhibited Pro transport at 5 and 30 min, 
with a higher effect at 5 min (~35% vs ~15-20%). Likewise, uptake of β-Ala was also 
reduced (~40-50%) by the two hormone concentrations assayed and at the two 
incubation times (Fig. 4c). These results suggested that PAT1 activity is also regulated 
by leptin. However, Western blot assays showed that the expression of PAT1 (~55 kDa) 
(Dorn et al. 2009) in the BBMV was not modified by the hormone.  (Fig. 5a)  
Because amino acid uptake via human PAT1 in Caco-2 cells is inhibited by activators 
of the cAMP pathway through inhibition of the Na+/H+ exchanger 3 (NHE3) activity 
(Anderson et al. 2005) and the mechanism of inhibition of β-Ala uptake by leptin did 
not seem to involve decrease of PAT1 abundance in BBMV, we decided to investigate 
whether a PKA-dependent pathway could be implicated in this leptin effect. The uptake 
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of 1 mM β-Ala was measured in Na+ medium at pH 6 in the presence of 8 nM leptin in 
control conditions and after pre-incubation of the cells with 1 µM H-89. As shown in 
Fig. 5b, H-89 did not modify β-Ala uptake, but clearly blocked the inhibitory effect of 
leptin on β-Ala uptake indicating PKA involvement. To check the possible participation 
of NHE3 on leptin inhibition of β-Ala uptake, we measured the effect of 8 nM leptin on 
1mM β-Ala uptake at pH 6 in both, Na+ and Na+- free medium, condition in which the 
activity of NHE3 is annulled. As it is shown in figure 5c, in the absence of Na+ there 
was a reduction on β-Ala uptake, similar to that for Pro shown in figure 4a, that was not 
modified by leptin, indicating that the hormone inhibition of β-Ala uptake is Na+-
dependent and may require NHE3 activity. 
 
DISCUSSION 
The present work enlarges previous data about leptin regulation of intestinal nutrient 
absorption by demonstrating in the human intestinal cell line Caco-2 that leptin, acting 
from the apical membrane, can rapidly inhibit sugar and amino acids uptake. This 
inhibition is accompanied by a decrease in the amount of SGLT1, B0AT1 and ASCT2 
proteins in the brush border membrane of the cells but not of PAT1.  
These results are in line with previous studies from our laboratory that have extensively 
demonstrated in rodents, in vitro and in vivo, the fast inhibitory effect of luminal leptin 
on sugar absorption, already observed after 2-3 min incubation with the hormone  
(Barrenetxe et al. 2001, Ducroc et al. 2005, Iñigo et al. 2004, Iñigo et al. 2007, Lostao 
et al. 1998, Sakar et al. 2009) and the decrease in the abundance of the Na+-glucose co-
transporter SGLT1 protein in the brush border membrane (Ducroc et al. 2005). These 
observations on murine intestine are now confirmed in the Caco-2 cell line, a model of 
human intestinal epithelium, in which the presence of leptin receptors is well 
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documented (Buyse et al. 2001). Here, apical leptin inhibits MG uptake after a short 
incubation period, and this inhibition is accompanied by a decrease in the amount of 
SGLT1 in the apical membrane of the cells. In contrast to the studies in rat (Barrenetxe 
et al. 2004), in Caco-2 cells, this effect is not PKA-dependent. 
In continuation with our studies, we recently demonstrated in rat, a short-term down-
regulation by luminal leptin of two of the Na+-dependent transporters involved in Gln 
absorption: ASCT2 and B0AT1 (Ducroc et al. 2010). In Caco-2 cells, the expression of 
ASCT2 has been demonstrated (Nose et al. 2010) and the presence of a Na+-dependent 
Gln transport system ascribed to system B has been described (Souba et al. 1992) 
although its molecular identity has not been identified yet. Here, we demonstrate 
functionally and biochemically in the Caco-2 cell line that both ASCT2 and B0AT1 are 
present and regulated by leptin. Moreover, we show that a PKA-dependent intracellular 
pathway is involved in leptin inhibition of Gln uptake. Since ASCT2 exhibits a 
micromolar K0.5 for Gln (Utsunomiya-Tate et al. 1996) whereas B0AT1 K0.5 is ~0.6-4 
mM (Broer et al. 2004, Broer 2008) we performed competition experiments to 
discriminate between these transporters. As previously reported in rat (Ducroc et al. 
2010), uptake of 20 µM Gln was not inhibited by 25 mM Phe, a specific substrate of 
B0AT1, indicating that the high affinity transporter ASCT2 is responsible for Gln 
uptake at that concentration. Since this transport can be decreased by leptin, it shows 
that ASCT2 is present in Caco-2 cells and is regulated by the hormone. Furthermore, 
direct measurement of ASCT2 protein, achieved by Western blot analysis, indicated that 
in the presence of Gln, leptin decreased the amount of ASCT2 in BBMV, as previously 
found in rat intestine (Ducroc et al. 2010). Uptake of 0.1 mM Phe, which is mainly 
mediated by B0AT1 (Broer 2008), was also inhibited by leptin, which decreased B0AT1 
abundance in BBMV as well. As it has been reported in rat intestine (Ducroc et al. 
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2010), the lower control uptake values for 0.1 mM Phe compared with the control 
uptake values for 0.1 mM Gln, would be explained by the lower affinity of B0AT1 
compared with ASCT2 [Broer et al. 2004, Broer 2008, Utsunomiya-Tate et al. 1996). 
Altogether these data confirm in the human model of epithelial intestinal cells the 
results found in rat intestine and demonstrate for the first time the expression of B0AT1 
protein in these cells. 
Caco-2 cell line also expresses the H+-dependent Pro and β-Ala transporter PAT1 
(Anderson et al. 2004, Chen et al. 2003, Thwaites et al. 1993) and it has been suggested 
that in differentiated Caco-2 cells, PAT1 is the major transporter for Pro (Metzner et al. 
2004). Here, we confirm the implication of PAT1 in the intestinal uptake of Pro, as the 
acidification of the medium significantly stimulated the uptake of the amino acid in the 
presence and the absence of Na+.  
The cooperative functional relationship between PAT1 and the Na+/H+ exchanger 
NHE3 (Anderson et al. 2004) could explain the Na+ dependence of Pro uptake herein 
found and previously observed in rat intestine (Iñigo et al. 2006). It is noteworthy that 
the assays to determine leptin effect on Pro and β-Ala uptake were performed in the 
presence of Na+ and pH 6. Leptin inhibited Pro and β-Ala uptake demonstrating the 
inhibitory effect of the hormone on PAT1 transporter in the Caco-2 cell line. The 
Western blot experiments, however, did not show reduction of PAT1 abundance in the 
apical membrane of the cells after treatment with the hormone. As previously 
mentioned, activity of the apical Na+/H+ exchanger maintains the H+ electrochemical 
gradient necessary for the correct functionality of PAT1 (Anderson et al. 2004, Seidler 
et al. 2008). Moreover, it has been demonstrated that activation of cAMP/PKA pathway 
decreases the activity of the Na+/H+ exchanger NHE3 (Anderson & Thwaites 2005)  and 
indirectly inhibits PAT1, in line with the fact that PAT1 has no intracellular PKA 
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phosphorylation sites (Chen et al. 2004). On the other hand, it is well known that leptin 
is able to activate PKA (Barrenetxe et al. 2004, Than et al. 2011). Our results with H-89 
are in accordance with these data since we show the implication of PKA in leptin 
inhibition of β-Ala uptake and that leptin does not exert its inhibitory effect in the 
absence of sodium when the Na+/H+ exchanger activity is blunted. Interestingly, it has 
been demonstrated that NHE1 activity is regulated by leptin in erythrocytes where 
leptin receptors are expressed (Konstantinou-Tegou et al. 2001), which support that the 
Na+/H+ exchangers are leptin targets. Therefore, we suggest that leptin would alter the 
activity of the Na+/H+ exchanger  with the corresponding decrease in the H+ gradient, 
PAT1 activity and final  reduction of Pro and β-Ala uptake. Therefore, we suggest that 
the primary action of leptin would be the inhibition of NHE3 activity with the 
corresponding decrease in the H+ gradient, PAT1 activity and finally a reduction of Pro 
and β-Ala uptake. 
It has been reported in monolayer of Caco-2 cells grown and differentiated on 
permeable supports that luminal leptin produces, after 30 min incubation, an increase in 
both uptake of dipeptides by the H+-dependent transporter PEPT1 and translocation of 
the transporter from the intracellular pool to the plasma membrane (Buyse et al. 2001). 
In the case of PEPT1 and under those experimental conditions, it is possible that, 
besides the inhibitory effect on NHE3 activity, leptin could up-regulate PEPT1 
expression in the plasma membrane, which would overcome the effect on dipeptides 
uptake related to a reduction of the H+ gradient. 
 Leptin also enhances CD147/MCT-1 mediated uptake of butyrate but, in this case, the 
effect requires at least 12 h and is due to increase in the intracellular pool of MCT-1 and 
translocation of CD147/MCT-1 to the apical plasma membrane (Buyse et al. 2002).  
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In summary, leptin modulates sugar and amino acid uptake in human Caco-2 cell line in 
a short-term manner, in line with its physiological role as gastric delivered hormone 
acting on epithelial cells of the small intestine. The present results together with 
previous data from the literature show that leptin regulation of nutrients absorption is 
fast (occurring already at 5 min); is reversible (Iñigo et al.  2007); produces increase or 
decrease on the absorption which is around 35 % of the control values and never higher 
that 50%; affects various nutrients including sugars (Barrenetxe et al. 2001, Ducroc et 
al. 2005, Lostao et al. 1998, Sakar et al. 2009) amino acids (Ducroc et al. 2010) 
peptides (Buyse et al. 2001) and short chain fatty acids (Buyse et al. 2002); and in most 
cases involves the recruitment or insertion of the corresponding transporters into the 
apical membrane of the enterocytes (Buyse et al. 2001, Ducroc et al. 2005, Ducroc et al. 
2010). Therefore, leptin is a major physiological molecule which participates in the 
modulation of nutrients absorption adjusting their entry into the enterocytes according 
to its needs. 
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LEGENDS TO FIGURES 
 
Figure 1 Effect of leptin on MG uptake by Caco-2 cells. (a) MG (0.1 mM) uptake after 
5 and 30 min incubation was measured in the absence and in the presence of 0.2 or 8 
nM leptin. Data (n= 47-53) are expressed as % (mean ± SEM) of control values (0 
leptin). *p<0.05; ***p<0.001 vs control. (b) Expression of SGLT1 protein (75 kDa) in 
BBMV of Caco-2 cells obtained after 30 min incubation of the cells with 0.1 mM MG 
in the presence and in the absence of 8 nM leptin. The intensity of the immunoreactive 
bands (transporter/β-actin) is expressed in % of control (MG) n=3. A representative 
Western blot image is also represented. ** p<0.01 vs MG. (c) Effect of leptin and the 
PKA inhibitor H-89 on MG uptake. After 30 min pre-incubation of the cells without or 
with 1µM H-89, 0.1 mM MG patake (30 min) was measured in the absence of leptin 
(control; H-89) and in the presence of the hormone at 8 nM (leptin; leptin+H-89).  Data 
(n=12-48) are expressed as % (mean ± SEM) of control uptake. *** p< 0.001 vs. 
control. 
 
Figure 2 Effect of leptin on Gln and Phe uptake by Caco-2 cells. Uptake of 0.1 mM Gln 
(a) or 0.1 mM Phe (c) was measured in the absence and in the presence of 0.2 and 8 nM 
leptin in Na+ buffer after 5 and 30 min incubation. We took advantage of the distinct 
affinity of Gln transporters (ASCT2 micromolar and B0AT1 millimolar range) to 
discriminate putative transporters affected by leptin in substrate competition 
experiments (b). Uptake of 20 µM Gln was thus determined in the presence of 8 nM 
leptin and 25 mM Phe at 30 min incubation. (d) Uptake of 0.1 mM Gln was measured 
for 30 min in the presence and absence of 8 nM leptin in Na+ buffer and Na+-free buffer 
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(D). Data in each graphic (n=13-38) are expressed as % (mean ± SEM) of control 
uptake (0 leptin, +Na+). * p<0.05; ** p< 0.01; *** p<0.001 vs control. 
 
Figure 3 (a) Expression of ASCT2 (~60 kDa) and B0AT1 (~60 kDa) protein in BBMV 
of Caco-2 cells. BBMV were obtained after 30 min incubation of the cells with 0.1 mM 
Gln in the presence and in the absence of 8 nM leptin. The intensity of the 
immunoreactive bands (transporter/β-actin) is expressed in % of control (Gln; n=3). A 
representative Western blot image is also represented. * p<0.05; ** p<0.01 vs Gln. (b) 
Effect of leptin and the PKA inhibitor H-89 on Gln uptake. After 30 min pre-incubation 
of the cells without or with 1µM H-89, 0.1 mM Gln uptake (30 min) was measured in 
the absence of leptin (control; H-89) or in the presence of the hormone at 8 nM (leptin; 
leptin+H-89). Data (n=12-36) are expressed as % (mean ± SEM) of control. ** p<0.01; 
*** p<0.001; vs control; ## p<0.01 vs leptin. 
 
Figure 4 Effect of leptin on Pro and β-Ala uptake by Caco-2 cells. (a) Uptake of 1 mM 
Pro was first measured in Na+-free medium (-Na+) and in Na+ medium (+Na+) at pH 7.5 
and pH 6 (n= 20-30). Uptake of 1 mM Pro (b) or β-Ala (c) at pH 6 in Na+ medium was 
measured in the absence and in the presence of 0.2 and 8 nM leptin, after 5 and 30 min 
incubation. Data in b and c (n= 20-33) are expressed as % (mean ± SEM) of control 
value (0 leptin). *p< 0.05; ** p< 0.01; ***p<0.001 vs pH 7.5 (A) or control (B, C); # p< 
0.05; ## p< 0.01 vs Na+-free medium. Control values for Pro uptake in b were 1.1±0.05 
and 2.05 ±0.66 nmol mg-1 of protein at 5 and 30 min respectively. Control values for β-
Ala uptake in c were 0.37 ±0.02 and 2.05±0.66 nmol mg-1 of protein at 5 and 30 min 
respectively. 
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Figure 5 (a) Effect of leptin on PAT1 protein expression in BBMV of Caco-2 cells. 
BBMV were obtained after 30 min incubation with 1 mM β-Ala in the absence and in 
the presence of 8 nM leptin (a). The intensity of the ∼50 kDa immunoreactive bands 
(transporter/β-actin) is expressed in % of control (β-Ala; n=4). A representative Western 
blot image is also represented. (b) Effect of leptin and the PKA inhibitor H-89 on β-Ala 
uptake. After 30 min pre-incubation of the cells without or with 1µM H-89, 0.1 mM Gln 
uptake (30 min) was measured in the absence of leptin (control; H-89) and in the 
presence of the hormone at 8 nM (leptin; leptin+H-89). (c) Uptake of 1mM β-Ala in the 
absence and in the presence of 8 nM leptin after 30 min in Na+ buffer (+Na+) and Na+-
free buffer (-Na+). Data in each graphic (n=6-32) are expressed as % (mean ± SEM) of 
control value (Na+). *p< 0.05; **p< 0.01 vs; *** p< 0.001 vs control; ### p<0.001 vs 
leptin. 
 
